(Q36711706)

15 August 2017

title

Effect of intravenous immunoglobulin on prednisone dose in patients with pemphigus vulgaris (English)

1 reference

15 August 2017

1 reference

pemphigus vulgaris

1 reference

Nicole Mittmann

1

1 reference

15 August 2017

Brian Chan

2

1 reference

15 August 2017

Sandra Knowles

3

1 reference

15 August 2017

P Régine Mydlarski

4

1 reference

15 August 2017

Lidia Cosentino

5

1 reference

15 August 2017

Neil Shear

6

1 reference

15 August 2017

publication date

1 September 2006

1 reference

Journal of cutaneous medicine and surgery

15 August 2017

published in

1 reference

15 August 2017

volume

10

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

222-227

1 reference

Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2310%2F7750.2006.00053

Guidelines for the management of pemphigus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F7750.2006.00053

Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F7750.2006.00053

Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F7750.2006.00053

Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F7750.2006.00053

Clinical uses of intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F7750.2006.00053

Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F7750.2006.00053

The role of IVIg treatment in severe pemphigus vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F7750.2006.00053

21 January 2018

Identifiers

DOI

10.2310/7750.2006.00053

1 reference

15 August 2017

1 reference